ClinicalTrials.Veeva

Menu

Impact of Probiotics Supplement on the Gut Microbiota in Caesarean-born Infants

T

Tongji University

Status

Unknown

Conditions

Gut Microbiota

Treatments

Dietary Supplement: probiotics

Study type

Interventional

Funder types

Other

Identifiers

NCT05086458
SHSYEK-001

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of probiotics on the gut microbiota of infants born by cesarean section.

Full description

This study aims to examine the impact of probiotics administration on the gut microbiota of infants born by cesarean section. Birth,14 days and 42 days data will be collected and put into analysis to provide some suggestions on the probiotics use in the clinical for the infants born by cesarean section.

Enrollment

30 estimated patients

Sex

All

Ages

1 hour to 42 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Neonates born by caesarean section

Exclusion criteria

  • Gestational weeks <37 Birth weight <2500g or ≥4000g History of asphyxia anoxia at birth With congenital metabolic diseases or hereditary diseases With gastrointestinal diseases With infectious diseases

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

No intervention
No Intervention group
Description:
the patients in this arm will not receive probiotics.
Dietary Supplement
Experimental group
Description:
the patients in this arm will receive probiotics blend of Bifidobacterium longum, Lactobacillus acidophilus, Enterococcus faecalis for 2 weeks.
Treatment:
Dietary Supplement: probiotics

Trial contacts and locations

1

Loading...

Central trial contact

Rong Yang, MD; Hui Zhong

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems